Toronto Dominion Bank
EW icon

Toronto Dominion Bank’s Edwards Lifesciences EW Stock Holding History

Toronto Dominion Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-306,600
Closed -$9.45M – 1518
2019
Q2 		$9.45M Buy
+306,600
New +$18.5M 0.02% 505

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Toronto Dominion Bank's EW Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Edwards Lifesciences (EW) stake by 38% in Q1 2026, selling an estimated $10.6M and leaving 213,373 shares worth $17.1M. The position accounts for 0.02% of the portfolio, ranked #473.

Toronto Dominion Bank first reported a position in EW in Q4 2013 and has held it in 50 quarters since. The position peaked at $73.6M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Toronto Dominion Bank held 213,373 shares of Edwards Lifesciences worth $17.1M as of Q1 2026.
  • Toronto Dominion Bank sold 128,909 Edwards Lifesciences shares in Q1 2026, an estimated $10.6M.
  • Edwards Lifesciences made up 0.02% of Toronto Dominion Bank's portfolio in Q1 2026, its #473 holding.
  • Toronto Dominion Bank first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Edwards Lifesciences position peaked at $73.6M in Q4 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.